A landmark randomized controlled trial conducted across sixteen primary care clinics in Kenya demonstrates that an integrated generative AI decision support tool safely enhances clinical documentation and treatment planning, though it does not significantly alter short-term patient outcomes. Published recently in Nature Medicine by researchers from the University of Birmingham and the National Institute for Health and Care Research Biomedical Research Center, the study addresses a critical gap in digital health by testing whether artificial intelligence can improve actual patient-level results rather than merely simulating clinician performance. The trial enrolled over nine thousand six hundred patients and randomly assigned participating clinicians to standard electronic medical record workflows or systems augmented with AI Consult, a large language model-based diagnostic aid. Operating invisibly during consultations, the tool delivered real-time suggestions while preserving full clinical autonomy and avoiding disruption to patient interactions. Results indicated no statistically significant difference in fourteen-day treatment failure rates between AI-assisted and standard care groups, with twenty-two percent versus twenty percent respectively. Crucially, safety metrics remained identical, showing no increase in hospitalizations or fatalities. Despite the absence of measurable short-term clinical improvements, the AI intervention produced notable operational benefits. Independent reviewers confirmed higher quality in clinical documentation and treatment planning for AI-supported encounters. Overall antibiotic utilization remained consistent, yet the AI-guided group achieved lower antibiotic-related costs through more economical prescribing decisions. Patient satisfaction scores were unchanged, confirming that the technology integrates seamlessly without eroding trust or altering the care experience. Lead investigators emphasize that primary care predominantly manages self-limiting conditions, where baseline outcomes are already favorable. Consequently, even meaningful refinements in clinical reasoning yield modest patient-level changes that typically require studies exceeding one hundred thousand participants to detect reliably. The findings establish a critical baseline for AI deployment in routine healthcare settings, validating safe workflow integration while tempering expectations regarding immediate clinical impact. Researchers note that the trial architecture provides a reusable framework for future evaluations across diverse healthcare systems, including high-income environments where baseline care standards are already elevated.